Sponsors and Exhibitors

BioIVT is a leading global provider of research models and value-added research services for drug discovery and development. We specialize in control and disease-state biospecimens including human and animal tissues, cell products, blood and other biofluids. Our unmatched portfolio of clinical specimens directly supports precision medicine research and the effort to improve patient outcomes by coupling comprehensive clinical data with donor samples. BioIVT

Certara accelerates medicines using proprietary biosimulation software, technology and services to transform traditional drug discovery and development. Its clients include more than 2,000 biopharmaceutical companies, academic institutions, and regulatory agencies across 62 countries. Certara

Discovery Life Sciences combines the world’s largest commercial biospecimen inventory and procurement network with preeminent multi-omic service laboratories to accelerate precision medicine programs for cancer, infectious disease, and other complex conditions.

With the company acquisition of In Vitro ADMET Laboratories (IVAL) and the Gentest® business unit, part of Corning Incorporated’s Life Sciences business, Discovery is established as a leading provider of in vitro drug experimental systems to the pharmaceutical and life sciences industry. Discovery Life Sciences

Eurofins Discovery accelerates the critical drug discovery endeavor for our global clients through decades of experience and flexible solutions. We provide comprehensive services from assay-ready development to DiscoveryOne™ integrated programs; chemistry, in vitro safety and efficacy phenotypic assays, ADME-tox and pre-clinical pharmacology. Whether you require outsourcing needs or perform research in-house, Eurofins Discovery Services and Eurofins DiscoverX product solutions empowers R&D through IND. Eurofins Discovery

Pharmaron is a premier R&D service provider for the life sciences industry. Founded in 2004, Pharmaron has invested in its people and facilities, and established a broad spectrum of research, development and manufacturing service capabilities throughout the entire drug discovery, preclinical and clinical development process across multiple therapeutic modalities, including small molecules, biologics and CGT products. With over 17,000 employees and operations in China, the U.S., and the U.K., Pharmaron has an excellent track record in the delivery of R&D solutions to its partners in North America, Europe, Japan and China. Pharmaron

SEKISUI XenoTech is a global CRO for ADME/DMPK/DDI assays and test systems. Specializing in Enzyme Inhibition and Induction, Drug Transporters, Metabolite ID and Metabolic Stability testing, as well as an extensive selection of Hepatocytes and DMPK-focused test systems, we deliver value to our customers and impart CONFIDENCE INSPIRED BY QUALITY. SEKISUI XenoTech

SOLVO Biotechnology, now a subsidiary of Charles River Laboratories, has pioneered ADME-Tox research for over 20 years to support drug development programs for hundreds of clients worldwide. Whether you need basic screening, custom assay development, comprehensive regulatory studies, or advanced mechanistic investigations, we can help. SOLVO is a trusted collaborative research partner who brings focused scientific expertise and an in-depth understanding of regulatory guidelines to your projects. SOLVO Biotechnology

BioAgilytix is a leading global contract research organization focused on supporting pharmaceutical and biotech partners in all phases of drug development. With laboratory locations in North Carolina’s Research Triangle Park; Cambridge, Massachusetts; San Diego, California; Melbourne and Brisbane, Australia and Hamburg, Germany, BioAgilytix provides PK, immunogenicity, biomarkers, and cell-based assay services supporting the development and release testing of therapeutics across a number of industries and disease states. BioAgilytix

Frontage Laboratories, Inc. is a contract research organization (CRO) that provides integrated, scientifically-driven, product development services throughout the drug discovery and development process to enable pharmaceutical and biotechnology companies to achieve their development goals. Comprehensive services include drug metabolism and pharmacokinetics, analytical testing and formulation development, preclinical and clinical trial material manufacturing, bioanalysis, preclinical safety and toxicology assessment and early phase clinical studies. Rigorous scientific expertise, high quality standards and regulatory compliance is committed to every program. Frontage has enabled many innovator, generic and consumer health companies of all sizes to advance hundreds of molecules through development and file regulatory submissions in global markets allowing for successful development of important therapies and products for patients worldwide. Frontage Laboratories

CRO specializing in nonclinical and analytical drug discovery and development services. Inotiv

Expanding the precious gift of organ donation by minimizing discard, Novabiosis, Inc. works directly with regulated US Organ Procurement Organizations (OPO’s) to facilitate the placement of whole non-transplantable organs and tissues for research. Through our network of OPO’s, we can supply most non-transplantable organs and tissues for research including: liver, lung, intestine, pancreas, kidney, spleen, brain, eye, and birthing tissue.

Another aspect of our business is the isolation and cryopreservation of high-quality human primary cells. With direct access to sourcing, we can be very selective on the quality of organs we use for our primary cell isolations. We have the ability to isolate cells immediately upon organ recovery, thus minimizing logistical challenges that can greatly impact cell quality and yield. Human primary cells offered by Novabiosis, Inc include cells from the: Liver, Lung, Kidney, and Intestine. Our key products include: Hepatocytes, Kupffer, and Stellates cells from the Liver; Glomerular Endothelial Cells, Proximal Tubules, and Podocytes from the Kidney; and Epithelial and Myofibroblast from the Intestine. In addition to our off-the-shelf products, Novabiosis offers unmatched custom isolation options.

In Q4 of 2022, Novabiosis will also offer animal primary hepatocytes, including dog, primate, and a variety of rodent strains. Novabiosis, Inc

Thermo Fisher Scientific Inc. is the world leader in serving science. Our Mission is to enable our customers to make the world healthier, cleaner and safer. Whether our customers are accelerating life sciences research, solving complex analytical challenges, increasing productivity in their laboratories, improving patient health through diagnostics or the development and manufacture of life-changing therapies, we are here to support them. Our global team delivers an unrivaled combination of innovative technologies, purchasing convenience and pharmaceutical services through our industry-leading brands, including Thermo Scientific, Applied Biosystems, Invitrogen, Fisher Scientific, Unity Lab Services, Patheon and PPD. Thermo Fisher Scientific

Serving clients for 25 years, Simulations Plus is a leading provider in the biosimulation market providing software and consulting services supporting drug discovery, development, research, and regulatory submissions. We offer solutions that bridge machine learning, physiologically based pharmacokinetics, quantitative systems pharmacology/toxicology, and population PK/PD modeling approaches. Our technology is licensed and applied by major pharmaceutical, biotechnology, and regulatory agencies worldwide. Simulations Plus

Alliance Pharma is a contract research organization specializing in clinical, GLP, and discovery bioanalytical services for both small and large molecules, as well as preclinical drug metabolism and pharmacokinetic support. Founded in 2008, our 37,000 square ft facility is located in Malvern, Pennsylvania. Business Philosophy: Trust, Communication, Scientific Excellence and Quality. Alliance Pharma

Patented Human Primary Cell “gut on a chip” model. Altis Biosystems, Inc.

Personalized service, exceptional science, superior technology - the perfect combination.

Alturas Analytics provides GLP and non-GLP bioanalytical LC-MS/MS and GC-MS/MS quantitation and PK/TK analysis from discovery through late phase clinical trials. With extensive expertise analyzing small chemical and biomolecules, oligonucleotides, and drug conjugates in all matrices, we deliver results on-time with scientific integrity that exceeds industry standards. Alturas Analytics

Everyone at AnaBios shares a passion and commitment to make a difference in the development of promising new therapies and cures for patients by reducing the time and expense related to clinical trial failures. We do this by generating highly valuable, predictive human data in advance of clinical trials, ensuring the selection of the most effective and safest drugs. Through proprietary technology based on the use of human donor organs and tissues, we study ex vivo human responses to drugs and further investigate the molecular and functional basis of relevant human physiology. Our research focuses primarily on the areas of high, unmet medical need, including cardiac disease and safety, pain, PKD kidney disease and neurodegeneration. In partnership with Fortune 500 pharmaceutical companies, contract research organizations and universities, our mission is to develop therapeutic advancements to help patients live longer, healthier and more productive lives. ​Located in San Diego, CA (USA), AnaBios products and services are marketed directly, as well as through distributors and partners worldwide. AnaBios also drives an internal drug discovery platform via in-licensed programs from partners in the pharmaceutical industry and academia. AnaBios

Aragen is a trusted R&D and manufacturing partner to the global life sciences industry. From concept to commercial, we transform your ideas into solutions for better health. Whether large pharma or biotech, an agrochemical or animal health company, we provide you global resources and proven capabilities at every stage of the biopharma lifecycle, in small and large molecules. Our ability to offer end-to-end solutions or support standalone programs is underpinned by an innovation mindset, enabling technologies, and a partnership approach to every engagement. At Aragen, we recognize your work is vital, urgent and impacts lives. Our purpose, ‘In every molecule is the possibility for better health’ motivates us to drive the success of your programs, so that we can together transform hope into health for millions of people around the world. Aragen Life Sciences

As one of the world’s largest suppliers of custom carbon-14 radiochemicals, curachem is located in South Korea and carrying out the most challenging synthetic projects for our global customers. Curachem can also prepare C-14 radiolabeled API for Phase I, mass balance and microdosing (phase 0 and enhanced Phase I) studies. CURACHEM

Cypex specialises in the production of high quality recombinant enzymes including human CYPs, AOX, ALDH, GSTs and SULTs, and a range of CYPs from other species. Also available are antibodies, purified CYPs, substrates and inhibitors. Contract services include CYP inhibition, protein expression (let us know if there is something not in our catalogue that you need) and metabolite generation. All products and services are covered by Cypex’s ISO9001:2015 accredited QA system. Cypex Ltd

Cyprotex (www.cyprotex.com) was founded in 1999 and specialises in in vitro and in silico ADME-Tox. The company has sites in the UK and US. In 2016, Cyprotex was acquired by Evotec AG (www.evotec.com). As a whole, the Group offer expert support from early discovery through to preclinical development and beyond. Cyprotex US LLC

GenoMembrane Co., Ltd specializes in the research and development of drug transporters. We provide transporter-related products and research services. In order to contribute to pharmacokinetic study, we offer ABC transporter vesicle products and transiently expressed SLC transporter cells to help our clients to facilitate the drug discovery. GenoMembrane

Hypha Discovery is a specialist CRO providing scalable synthesis, purification and identification of all types of phase 1 and phase 2 drug metabolites to pharmaceutical companies worldwide. Hypha Discovery

InterVivo Solutions (IVS) is a preclinical in vivo CRO providing research services using translational animal models for efficacy, pharmacokinetics, safety and toxicology, including bioanalytical and imaging support. InterVivo is unique in its offering of translational models and transformative research services to improve the clinical success of NCEs. InterVivo has extensive experience evaluating the in vivo drug metabolism and pharmacokinetics properties of drugs, having tested hundreds of new chemical entities in standardized screening studies as well as more advanced lead optimization and characterization protocols. Together with it’s sister company, Transpharmation, IVS employs upwards of 120 qualified staff trained to support the scientific operations of the company across its’s locations in Canada, The UK, Ireland and Poland. InterVivo Solutions/Transpharmation

Our mission is to develop software to boost drug design and optimization processes. We also do contract research organization on their fields for several pharmaceutical companies abroad. We are working in collaboration with Molecular Discovery Ltd on the research and development of several solutions, by providing differentiated products and services to extract and transform the data into information, we go beyond reducing the make-design cycle in drug discovery for both small and macromolecules. Lead Molecular Design

LifeNet Health LifeSciences leads the way in human in vitro biology for both non-diseased and diseased research needs. LifeSciences combines innovative, technology-driven research and development programs to create human tissue and cell-based research products and services. We meet the demand for primary human cells, human tissues, and optimized media for scientific research, drug discovery, and safety testing. The application of 3D human cellular models and the use of human-derived hydrogels enables significant scientific improvements for precise biologic experiments. Our growing portfolio of best-in-class solutions expedites the research curve and enables the scientific community to develop and fine-tune new, safe therapies.

LifeNet Health LifeSciences

Newcells Biotech are a fast-growing team of global scientific and industry experts based in the Helix Science Campus of Newcastle-upon-Tyne in the UK. We provide in vitro models to most accurately predict in vivo outcomes, building confidence in the decision making process. Using our expertise in iPSCs, cellular physiology and organoid technology, we have built functional pre-clinical in vitro models of the retina in the form of fully developed retinal organoids and RPE cells. Newcells Biotech

Quotient Sciences is a drug development and manufacturing accelerator providing integrated programs and tailored services across the entire development pathway. Cutting through silos across a range of drug development capabilities, we save precious time and money in getting drugs to patients. Everything we do for our customers is driven by an unswerving belief that ideas need to become solutions, molecules need to become cures, fast. Because humanity needs solutions, fast. Quotient Sciences

Protein Profiling for DMPK and Drug Safety. SIGNATOPE

TissueVision offers multiplexed 3D tissue imaging and analysis. TissueVision Inc.

TNO with 3500 FTE is a research & technology organization involved in developing innovative platforms in biomedical health. Besides disease models in the field of NASH, NAFLD, Fibrosis and Diabetes, target safety assessment we have a broad expertise in the field of DMPK/ADME. We offer in vitro and ex vivo platforms to predict Pharmacokinetics (PK) and metabolism and u-dosing/tracer AMS services to measure PK, Absolute BA, mass balance and metabolism in early clinical development as measuring fluxes (dynamic biomarkers) showing early efficacy of small/large drug candidates.

The Drug Interaction Database (DIDB), part of UW Drug Interaction Solutions supports pharmaceutical scientists and clinicians in their evaluation of pharmacokinetic-based drug interactions and drug safety. The database contains reliable, up-to-date, qualitative, and quantitative information curated from human in vitro and clinical drug interaction, organ impairment, and pharmacogenetic studies. UW Drug Interaction Solutions

As a global company with operations across Asia, Europe, and North America, WuXi AppTec provides a broad portfolio of R&D and manufacturing services that enable global pharmaceutical and healthcare industry to advance discoveries and deliver groundbreaking treatments to patients. Through its unique business models, WuXi AppTec’s integrated, end-to-end services include chemistry drug CRDMO (Contract Research, Development and Manufacturing Organization), biology discovery, preclinical testing and clinical research services, cell and gene therapies CTDMO (Contract Testing, Development and Manufacturing Organization), helping customers improve the productivity of advancing healthcare products through cost-effective and efficient solutions. WuXi AppTec received AA ESG rating from MSCI in 2021 and its open-access platform is enabling more than 5,600 collaborators from over 30 countries to improve the health of those in need – and to realize the vision that "every drug can be made and every disease can be treated. WuXi AppTec